pr newswire alzpath - SERP Analysis

https://www.prnewswire.com/news-releases/alzpath-named-2025-bronze-edison-award-winner-for-its-proprietary-ptau217-antibody-a-key-biomarker-driving-blood-based-alzheimers-disease-diagnostics-302421879.html

https://www.prnewswire.com/news-releases/alzpath-signs-licensing-agreement-with-beckman-coulter-diagnostics-to-provide-proprietary-ptau217-antibody-to-develop-a-diagnostic-blood-test-for-alzheimers-disease-302196639.html

https://alzpath.bio/november-18-2024-biotechne-press-release/

https://alzpath.bio/march-18-2025-alzpath-named-fast-companys-most-innovative/

https://www.bioflorida.com/page/PRNewsUS?&rkey=20250325IO49137&filter=4860

https://alzpath.bio/march-25-2025-alzpath-adds-adds-biotech-veteran-to-board-of-directors-and-names-prominent-global-researcher-as-distinguished-scientific-advisor/

https://www.biospace.com/press-releases/neurocode-study-highlights-superior-performance-of-alzpath-ptau217-assay-in-alzheimers-diagnosis

https://aijourn.com/data-showcasing-alzpaths-proprietary-ptau217-antibody-at-ad-pd-2025-demonstrates-high-rate-of-reliability-and-scalability-for-alzheimers-disease-research-and-diagnosis/

https://finance.yahoo.com/news/alzpath-announces-licensing-agreement-roche-123000023.html

https://alzpath.bio/january-press-release/

https://x.com/PRNewswireIL/status/1851630717773418643

https://themalaysianreserve.com/2024/02/29/alamar-biosciences-and-alzpath-inc-announce-strategic-supply-agreement-for-ptau217-antibody-to-advance-alzheimers-disease-research/

https://alzpath.bio/april-7-2025-alzpath-named-edison-award-winner/

https://fox59.com/business/press-releases/cision/20230718LN60327/alzpath-announces-new-funding-from-the-alzheimers-drug-discovery-foundation-addf-to-advance-a-novel-diagnostic-blood-based-assay

https://www.crunchbase.com/organization/alzpath

https://x.com/AlZpath

https://finance.yahoo.com/news/alzpath-proprietary-ptau217-antibody-named-141200478.html

https://alzpath.bio/january-27-2024-alzpath-appoints-mike-banville-as-ceo/

https://www.bioflorida.com/page/PRNewsUS?&rkey=20250417IO67178&filter=4860

https://www.linkedin.com/posts/alzpath-inc_alzpath-adpd-press-release-activity-7313588415365533698-2Fvg

https://tracxn.com/d/companies/alzpath/__xyi2oC02iOOjcp8cMYGXVp7-ek--nZIB_-nL-T3WpcI

https://www.swisslifesciences.com/gate/v3/news.php?next=441

https://alzpath.bio/may-2024-press-release/

https://kxadvisors.com/insights/blood-biomarkers-in-alzheimers-disease/

https://sdbn.org/san-diego-biotech-news/2025/04/01/data-showcasing-alzpaths-proprietary-ptau217-antibody-at-ad-pd-2025-demonstrates-high-rate-of-reliability-and-scalability-for-alzheimers-disease-research-and-diagnosis/

https://www.wjtv.com/business/press-releases/cision/20250318LN43682/alzpath-named-to-fast-companys-annual-list-of-the-worlds-most-innovative-companies-of-2025

https://www.finansavisen.no/borsmeldinger/2025/01/15/4f2f994d-3ed8-4bd7-836d-a5d136a6224f/beckman-coulter-introduces-cutting-edge-research-use-only-assays-for-neurodegenerative-disease-research

https://alzheimersnewstoday.com/news/blood-test-alzheimers-biomarkers-may-speed-treatment-start/

https://firstwordhealthtech.com/river/tag/fw_company/Linus%20Health

https://www.linkedin.com/posts/tstoica_neurocode-study-highlights-superior-performance-activity-7292352182501130240-u215

https://alzpath.bio/july-9-2024-alzpath-welcomes-new-ceo/

https://pr.boreal.org/article/Neurocode-Launches-Groundbreaking-pTau217-Blood-Test-for-Alzheimers-Disease-Clinical-Diagnosis?storyId=65e5c7ed8f077bbdb863579e

https://www.helse-stavanger.no/4ac27a/siteassets/documents/predictom/1-predictom-international-press-release.docx

https://firstwordpharma.com/story/5835163

https://kxadvisors.com/author/jcapuccino/

https://twitter.com/startuphealth/status/1813651210374692952

https://www.crunchbase.com/organization/beckman-coulter/company_overview/overview_timeline

https://sdbn.org/san-diego-biotech-news/2025/04/07/alzpath-named-2025-bronze-edison-award-winner-for-its-proprietary-ptau217-antibody-a-key-biomarker-driving-blood-based-alzheimers-disease-diagnostics/

https://wire.expertini.com/search/brand-initiatives-articles-global/

https://alzpath.bio/july-15-2024-press-release-alzpath-beckman-coulter-partnership/

https://pressreleasehub.pa.media/article/diadem-unveils-novel-findings-on-early-alzheimers-disease-detection-using-p53-specific-antibody-at-ctad-2024-31199.html

https://www.neurologyadvisor.com/news/early-detection-of-alzheimer-disease-plasma-assays-commercially-available/

https://alzpath.bio/july-29-2024-press-release-aaic/

https://school.wakehealth.edu/research/institutes-and-centers/sticht-center/alzheimers-disease-research-center/research-news-and-events

https://firstwordpharma.com/story/5838464

https://ir.labcorp.com/news-releases/news-release-details/labcorp-launches-ptau217-blood-biomarker-test-accelerate-path

https://www.cbinsights.com/company/neurocode-labs

https://matter.health/posts/alzheimers-association-and-matter-select-5-finalists-for-pitch-competition/

https://www.news-journal.com/alzpath-adds-biotech-veteran-to-board-of-directors-and-names-prominent-global-researcher-as-distinguished/article_372293e9-0056-5432-9a3a-c1f0ddc9189d.html

https://www.pharmexec.com/view/genova-early-detection-alzheimer

https://leadiq.com/c/beckman-coulter-diagnostics/5a1d8a76240000240063eebd

https://fnih.org/press-release/fnih-biomarkers-consortium-announces-study-results-further-validating-blood-tests-for-alzheimers-disease/

https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.70054?af=R

https://alzpath.bio/addf-press-release/

https://6abc.com/alzheimers-disease-quest-diagnostics-blood-test-health-medicine/14351166/

https://www.helse-stavanger.no/4ac316/siteassets/documents/predictom/predictom-international-press-release-151123.docx

https://www.swedbank-aktiellt.se/telegram/bDv15aMc

https://www.drugdiscoveryonline.com/doc/us-nonprofit-italian-biotech-study-new-class-drugs-treat-alzheimer-s-disease-0001

https://www.sec.gov/Archives/edgar/data/1621459/000149315224029892/forms-1a.htm

https://imoscancer.org/In_the_news?rkey=20250417IO67178&filter=15146

https://alzpath.bio/feb2024-press-release/

https://www.counton2.com/business/press-releases/cision/20250325IO49137/alzpath-adds-biotech-veteran-to-board-of-directors-and-names-prominent-global-researcher-as-distinguished-scientific-advisor/

https://tracxn.com/d/acquisitions/acquisitions-by-bio-techne/__yFLwXFevAtGJz6T-knT9LMT69Km-ldjDS9tnaJKipaA

https://www.wgal.com/article/alzheimers-blood-test-step-closer-to-reality-study/46489033

https://www.fundslibrary.co.uk/FundsLibrary.DataRetrieval//Documents.aspx?type=packet_fund_doc_reports_and_accounts&id=d81888a3-e41b-4a18-bbcd-028797ec48e8&user=hl_website_documents

https://matter.health/posts/the-alzheimers-association-and-matter-select-neurotrack-as-winner-of-pitch-competition/

https://alzpath.bio/nov2022-press-release/

https://westernreservenews.com/VIDEO/WX/PRMEDICAL.html?start=216&filter=7024

https://pharmaphorum.com/news/alzpath-licenses-alzheimers-diagnosis-tech-roche

https://www.quanterix.com/press-releases/quanterix-announces-new-agreement-to-advance-blood-based-alzheimers-disease-detection/

https://za.investing.com/equities/techne-corp

https://alz-journals.onlinelibrary.wiley.com/doi/abs/10.1002/alz.13455

https://www.theglobeandmail.com/investing/markets/stocks/TRVN/pressreleases/16716010/global-alzheimer-s-disease-diagnostics-therapeutics-market-expected-to-reach-9-6-billion-by-2027/

https://themalaysianreserve.com/2025/04/17/global-alzheimers-disease-therapeutics-and-diagnostics-market-to-grow-at-15-1-cagr/

https://www.techdogs.com/tech-news/pr-newswire/genova-diagnostics-partners-with-neurocode-to-launch-innovative-alzheimers-assessment

https://www.stocktitan.net/news/TECH/bio-techne-and-al-zpath-announce-strategic-partnership-to-advance-dbmjpwteqxao.html

https://www.prweb.com/releases/alzheimer-s-disease-diagnostics-and-patient-services-company-alzpath-announces-novel-validated-and-scalable-assay-for-detection-of-phosphorylated-tau-217-in-blood-835609952.html

https://www.epicos.com/article/942082/prominence-advisors-ceo-bobby-bacci-named-finalist-ey-entrepreneur-yearr-2025-midwest

https://pressreleasehub.pa.media/article/biogen-beckman-coulter-and-fujirebio-to-collaborate-on-blood-based-biomarkers-and-test-for-tau-pathology-in-alzheimers-disease-23979.html

https://www.cnn.com/2024/01/22/health/alzheimers-blood-test-screening-study

https://www.businesswire.com/news/home/20250221466375/en/%2419.6-Bn-Alzheimers-Disease-Global-Markets-Therapeutics-and-Diagnostics-to-2029-Profiles-of-Leading-Players---AbbVie-Biogen-Eisai-Co-Eli-Lilly-and-Co.-and-F.-Hoffmann-La-Roche---ResearchAndMarkets.com

https://www.quanterix.com/press-releases/quanterix-announces-new-agreements-with-lilly-to-advance-alzheimers-disease-diagnosis-and-treatment/

https://www.einpresswire.com/article/818360368/glx-analytix-appoints-leading-diagnostic-biomarker-expert-as-chief-scientific-officer-and-unveils-groundbreaking-study

https://newsroom.questdiagnostics.com/2024-04-22-Quest-Diagnostics-Adds-p-tau217-Blood-Biomarker-Testing-to-Suite-of-Services-Designed-to-Assess-Risk-and-Help-Aid-Diagnosis-of-Alzheimers-Disease

https://alzpath.bio/wp-content/uploads/2022/11/ALZpath-November-Press-Release_Nov-22-2022-FINAL.docx.pdf

https://www.marketwatch.com/press-release/global-alzheimer-s-disease-therapeutics-and-diagnostics-market-to-grow-at-15-1-cagr-da5ebd38

https://www.darkdaily.com/2024/08/16/in-vitro-diagnostics-companies-race-to-develop-blood-based-tests-for-alzheimers-disease-data-suggest-a-worldwide-growing-market/

https://www.globenewswire.com/news-release/2025/01/09/3007192/28124/en/Alzheimer-s-Disease-Diagnostics-Research-Report-2024-2034-Global-Market-to-Reach-27-87-Billion-Focus-on-Cost-Effective-Alzheimer-s-Diagnostics-Gaining-Momentum.html

https://news.beckmancoulter.com/2025-01-15-Beckman-Coulter-Introduces-Cutting-Edge-Research-Use-Only-Assays-for-Neurodegenerative-Disease-Research

https://www.kget.com/business/press-releases/cision/20240304SF47555/neurocode-launches-groundbreaking-ptau217-blood-test-for-alzheimers-disease-clinical-diagnosis

https://www.pharmacytimes.com/view/fda-grants-breakthrough-device-designation-for-phospho-tau-217-to-help-detect-ad

https://www.ktalnews.com/business/press-releases/cision/20240305SF53086/alamar-biosciences-announces-the-commercial-launch-of-ultra-high-sensitivity-nulisaseq-cns-disease-panel-120-and-nulisaqpcr-ptau-217-assays

https://alzpath.bio/press-center/

https://www.stocktitan.net/news/DHR/beckman-coulter-introduces-cutting-edge-research-use-only-assays-for-t3w04y966ilv.html

https://www.globenewswire.com/news-release/2025/03/25/3048897/0/en/Splash-Clinical-and-C2N-Diagnostics-Partner-to-Transform-Global-Clinical-Trial-Recruitment-for-Alzheimer-s-Disease.html

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cognixion-launches-clinical-trial-for-late-stage-als-to-deliver-conver-998534

https://pmlive.com/pharma_news/roche-enters-licensing-agreement-with-alzpath-to-advance-alzheimers-blood-test/

https://www.businesswire.com/news/home/20241009892605/en/Amprion-Announces-Initial-Close-of-a-%2415M-Financing-to-Commercialize-Groundbreaking-Neurologic-Diagnostics